Bienfait KL - Search Results

1

Challenges in obtaining adequate genetic sample sets in clinical trials: the perspective of the industry pharmacogenomics working group.

Warner AW, Bhathena A, Gilardi S, Mohr D, Leong D, Bienfait KL, Sarang J, Duprey S, Franc MA, Nelsen A, Snapir A. Warner AW, et al. Among authors: bienfait kl. Clin Pharmacol Ther. 2011 Apr;89(4):529-36. doi: 10.1038/clpt.2010.305. Epub 2011 Feb 23. Clin Pharmacol Ther. 2011. PMID: 21346757

2

Improving clinical trial sampling for future research - an international approach: outcomes and next steps from the DIA future use sampling workshop 2011.

Warner AW, Bienfait KL, Bledsoe M, Burckart G, Flamion B, Knoppers B, Nelsen AJ, Rudman A, Sieffert NJ, Uyama Y. Warner AW, et al. Among authors: bienfait kl. Pharmacogenomics. 2013 Jan;14(1):103-12. doi: 10.2217/pgs.12.193. Pharmacogenomics. 2013. PMID: 23252952

3

Mobilizing pharmacogenomic analyses during clinical trials in drug development.

Bienfait KL, Shaw PM, Murthy G, Warner AW. Bienfait KL, et al. Pharmacogenomics. 2013 Jul;14(10):1227-35. doi: 10.2217/pgs.13.109. Pharmacogenomics. 2013. PMID: 23859576

4

Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG).

Bienfait K, Chhibber A, Marshall JC, Armstrong M, Cox C, Shaw PM, Paulding C. Bienfait K, et al. Hum Genet. 2022 Jun;141(6):1165-1173. doi: 10.1007/s00439-021-02282-3. Epub 2021 Jun 3. Hum Genet. 2022. PMID: 34081195 Free PMC article. Review.

5

An Exploratory Study Using Electronic Medical Records to Assess the Feasibility of Establishing Cohorts of Patients with Genetic Causes of Parkinson's Disease.

Lee SJ, Shaw PM, Thornton B, Kumar A, Eizik M, Goldstaub D, Braun T, Teper G, Pai JK, Chodick G, Bienfait K, Levitan D, Beller D, Chris Min K, Jonathan D, Voss T, Fox CS, Aubrey Stoch S, Struyk AF, Vainstein G. Lee SJ, et al. J Parkinsons Dis. 2022;12(5):1645-1653. doi: 10.3233/JPD-212703. J Parkinsons Dis. 2022. PMID: 35466950 Free PMC article.

6

Telephone-based cognitive-behavioral therapy for depression in Parkinson disease.

Dobkin RD, Menza M, Allen LA, Tiu J, Friedman J, Bienfait KL, Gara MA, Mark MH. Dobkin RD, et al. Among authors: bienfait kl. J Geriatr Psychiatry Neurol. 2011 Dec;24(4):206-14. doi: 10.1177/0891988711422529. J Geriatr Psychiatry Neurol. 2011. PMID: 22228827 Free PMC article. Clinical Trial.

7

The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease.

Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, Bienfait K, Dicke A. Menza M, et al. Mov Disord. 2009 Jul 15;24(9):1325-32. doi: 10.1002/mds.22586. Mov Disord. 2009. PMID: 19412944 Free PMC article. Clinical Trial.

8

Sleep disturbances in Parkinson's disease.

Menza M, Dobkin RD, Marin H, Bienfait K. Menza M, et al. Mov Disord. 2010;25 Suppl 1(Suppl 1):S117-22. doi: 10.1002/mds.22788. Mov Disord. 2010. PMID: 20187236 Free PMC article. Review.

9

The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease.

Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Bienfait K, Dicke A, Kusnekov A. Menza M, et al. Psychosomatics. 2010 Nov-Dec;51(6):474-9. doi: 10.1176/appi.psy.51.6.474. Psychosomatics. 2010. PMID: 21051678 Free PMC article.

10

A controlled trial of antidepressants in patients with Parkinson disease and depression.

Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, Bienfait K, Dicke A. Menza M, et al. Neurology. 2009 Mar 10;72(10):886-92. doi: 10.1212/01.wnl.0000336340.89821.b3. Epub 2008 Dec 17. Neurology. 2009. PMID: 19092112 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters